Sagimet Biosciences to Participate in the UBS Global Healthcare Conference – BioSpace

(Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic …

Continue

Do you trust this headline?

Based on recent headline ratings, 86% of this readership currently trusts the local media, which has an average score of 84% regionally and is currently trending positivepositive.

86%

Media Trust Score

Read All

News